TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference

TG Therapeutics (TGTX) Tops Q3 EPS by 6c

November 9, 2015 7:49 AM EST

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.28), $0.06 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $38.1 thousand versus the consensus estimate of $40 thousand.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

... More